Alignment Healthcare (NASDAQ:ALHC) CEO Sells $4,449,911.63 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 215,701 shares of the company’s stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $20.63, for a total transaction of $4,449,911.63. Following the sale, the chief executive officer directly owned 1,888,940 shares in the company, valued at $38,968,832.20. This trade represents a 10.25% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Price Performance

NASDAQ:ALHC traded up $0.48 during trading hours on Monday, hitting $20.98. The stock had a trading volume of 1,753,989 shares, compared to its average volume of 3,132,918. The company has a 50 day simple moving average of $19.29 and a two-hundred day simple moving average of $19.04. The firm has a market capitalization of $4.29 billion, a price-to-earnings ratio of -2,095.90, a P/E/G ratio of 3.00 and a beta of 1.20. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71. Alignment Healthcare, Inc. has a one year low of $11.63 and a one year high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter in the prior year, the firm posted ($0.16) earnings per share. The business’s quarterly revenue was up 44.4% on a year-over-year basis. Research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Several hedge funds have recently bought and sold shares of ALHC. Summit Securities Group LLC bought a new stake in Alignment Healthcare during the fourth quarter valued at approximately $26,000. Parallel Advisors LLC lifted its position in Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the third quarter valued at approximately $33,000. First Horizon Corp bought a new stake in Alignment Healthcare during the fourth quarter valued at approximately $39,000. Finally, GAMMA Investing LLC lifted its position in Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after purchasing an additional 987 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the company. TD Cowen raised their price target on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. Piper Sandler boosted their price objective on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a report on Tuesday, January 6th. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, March 7th. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a research report on Friday, January 30th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $24.75.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.